Background {#Sec1}
==========

The prevalence of chronic kidney disease (CKD) is estimated to be 8--16% worldwide, generating a heavy economic impact on society in both developed and undeveloped countries \[[@CR1]\]. The glomerular filtration rate (GFR) has generally been considered the vital indicator for predicting overall renal function. Therefore, accurate estimation of the GFR is important for assessing the severity and progression of CKD.

Serum creatinine is an easily measurable and widely available marker of renal function. However, its levels are affected by multiple factors, such as muscle mass, weight, gender, etc. \[[@CR2]\]. Cystatin C is a nonglycosylated low-molecular-weight protein that is in the cystatin superfamily of cysteine protease inhibitors. It is produced at a constant rate by all nucleated cells and is freely filtered by the glomerulus. Although the serum cystatin C level serves as a valuable tool for early detection of renal dysfunction, it has been reported to be influenced by age, gender, body mass index, smoking status, the C-reactive protein level, nephritis, and hypertension \[[@CR3]--[@CR6]\].

The estimated GFR (eGFR), calculated by different equations, is commonly used for clinical care and research. The Modification of Diet in Renal Disease (MDRD) equation, initiated in 1999 and based on the serum creatinine level, is still applied clinically after several modifications \[[@CR7], [@CR8]\]. Recently, new equations such as the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations based on cystatin C and/or serum creatinine have been recommended for clinical applications \[[@CR9], [@CR10]\]. Some reports showed an improved accuracy of the eGFR using the cystatin C-based eq. \[[@CR11], [@CR12]\]. However, it is still controversial whether cystatin C-based GFR-estimating formulae are superior to serum creatinine-based ones \[[@CR6]\].

Until now, limited data are available on the comparison of six GFR-estimating equations (CKD-EPI~scr~, CKD-EPI~cys~, CKD-EPI~scr_cys~, abbreviated MDRD, Chinese MDRD, and original MDRD) in Chinese CKD patients. The aim of this study was to identify the equation that is the most accurate and acceptable for predicting the GFR and the CKD stage in a large Chinese population in a single center.

Methods {#Sec2}
=======

Subjects {#Sec3}
--------

A total of 7676 Chinese participants who underwent GFR measurement using ^99^Tc^m^-diathylenetriamine pentaacetic acid (^99^Tc^m^-DTPA) scintigraphy from January 2009 to March 2016 in Nanfang Hospital, China, were observed. The following exclusion criteria were used: 1) younger than 18 years old or older than 65 years old (*n* = 1124); 2) obstructive nephropathy (*n* = 4060); 3) solitary kidney or a single kidney (*n* = 6); 4) urinary inflammation (*n* = 58); 5) acute renal insufficiency or injury (*n* = 10); 6) any history of malignancy or kidney surgery (*n* = 918); 7) hyperthyroidism (*n* = 4); 8) use of antibacterial agents within 2 weeks (*n* = 145); 9) malignant hypertension (*n* = 44). A total of 1307 patients were screened in the preliminary study, and 11 out of 1307 patients failed to meet diagnostic criteria of CKD who were excluded from the study. Finally, a total of 1296 eligible patients were enrolled in this study. The diagnostic criteria of CKD are in accordance with the K/DOQI practice guidelines. Written informed consent was obtained from each subject prior to participation. This study was approved by the Ethics Committee of the Nanfang Hospital of Sothern Medical University.

Measurement of reference GFR (rGFR) and CKD classification {#Sec4}
----------------------------------------------------------

The rGFR was measured by nuclear medicine techniques. Participants were well hydrated before examination. ^99^Tc^m^-DTPA (radiochemical purity, \>95%; percentage of ^99^Tc^m^-DTPA bound to plasma protein, \<5%) was provided by Guangzhou Atomic Isotope Hi-Tech Pharmaceutical Co., Ltd., China.

CKD was classified into five stages based on the rGFR values as follows \[[@CR13]\]: stage 1, rGFR ≥90 mL/min/1.73 m^2^; stage 2, 60 mL/min/1.73 m^2^ ≤ rGFR \<90 mL/min/1.73 m^2^; stage 3, 30 mL/min/1.73 m^2^ ≤ rGFR \<60 mL/min/1.73 m^2^; stage 4, 15 mL/min/1.73 m^2^ ≤ rGFR \<30 mL/min/1.73 m^2^; stage 5, rGFR \<15 mL/min/1.73 m^2^. Renal insufficiency was defined as rGFR \<60 mL/min/1.73 m^2^.

Measurement of serum creatinine and cystatin C levels {#Sec5}
-----------------------------------------------------

Serum creatinine and cystatin C levels were measured in the fasting state by a sarcosine oxidase assay kit (Sichuan Maker Biotechnology Co., Ltd., China) and an immunoturbidimetric assay kit (Beijing Leadman Biotechnology Co., Ltd., China) on an Olympus AU5421® analyzer, respectively.

The eGFR was calculated based on the serum creatinine and/or cystatin C levels using six estimating equations (Table [1](#Tab1){ref-type="table"}).Table 1Different equations for estimation of GFRSubjectsGenderScr (mg/dL)Scys (mg/L)Equation (mL/min/1.73 m^2^)CKD-EPI~scr~ (eGFR~scr~)female≤0.7141 × (Scr/0.7)^-0.329^ × 0.993^age^ × 1.018\>0.7141 × (Scr/0.7)^-1.209^ × 0.993^age^ × 1.018male≤0.9141 × (Scr/0.9)^-0.411^ × 0.993^age^\>0.9141 × (Scr/0.9)^-1.209^ × 0.993^age^CKD-EPI~cys~ (eGFR~cys~)female≤0.8133 × (Scys/0.8)^-0.499^ × 0.996^age^ × 0.932\>0.8133 × (Scys/0.8)^-1.328^ × 0.996^age^ × 0.932male≤0.8133 × (Scys/0.8)^-0.499^ × 0.996^age^\>0.8133 × (Scys/0.8)^-1.328^ × 0.996^age^CKD-EPI~scr~\_~cys~ (eGFR~scr~\_~cys~)female≤0.7≤0.8130 × (Scr/0.7)^-0.248^ × (Scys/0.8)^-\ 0.375^ × 0.995^age^\>0.8130 × (Scr/0.7)^-0.248^ × (Scys/0.8)^-\ 0.711^ × 0.995^age^\>0.7≤0.8130 × (Scr/0.7)^-0.601^ × (Scys/0.8)^-\ 0.375^ × 0.995^age^\>0.8130 × (Scr/0.7)^-0.601^ × (Scys/0.8)^-\ 0.711^ × 0.995^age^male≤0.9≤0.8135 × (Scr/0.9)^-0.207^ × (Scys/0.8)^-\ 0.375^ × 0.995^age^\>0.8135 × (Scr/0.9)^-0.207^ × (Scys/0.8)^-\ 0.711^ × 0.995^age^\>0.9≤0.8135 × (Scr/0.9)^-0.601^ × (Scys/0.8)^-\ 0.375^ × 0.995^age^\>0.8135 × (Scr/0.9)^-0.601^ × (Scys/0.8)^-\ 0.711^ × 0.995^age^abbreviated \_MDRD (eGFR~a~\_~MDRD~)186 × (Scr)^-1.154^ × (age)^-0.203^ × (×0.742 if female)Chinese \_MDRD (eGFR~c~\_~MDRD~)175 × (Scr)^-1.234^ × (age)^-0.179^ × (×0.79 if female)original MDRD (eGFR\_~MDRD~)186 × (Scr)^-1.154^ × (age)^-0.203^ × (×0.742 if female) × (×1.233 if Chinese)*Scr* serum creatinine, *Scys* serum cystatin C

Statistical analysis {#Sec6}
--------------------

Statistical analysis was performed using SPSS20.0 (SPSS Inc., Somers, NY, USA) and MedCalc13.0 (MedCalc, Mariakerke, Belgium). Quantitative data were tested for homogeneity of variance by the Kolmogorov-Smirnov one-sample test. Bland-Altman analysis was used to determine the agreement between the rGFR and eGFR values, which were calculated by different equations. The receiver operating characteristic (ROC) curve was used to determine the diagnostic power at predicting the renal insufficiency (ROC~60~) by the six different equations, with the results reported as the areas under the ROC curve (AUC~60~), sensitivity, and specificity. Kappa statistics were used to evaluate the agreement between stage classification from the rGFR values and from the eGFR values calculated by different equations, with the following interpretations: poor agreement (0--0.20), slight agreement (0.21--0.40), moderate agreement (0.41--0.60), good agreement (0.61--0.80), and excellent agreement (0.81--1.0). The paired sample t test was carried out to evaluate inter-group differences. Differences with *P* \< 0.05 were considered statistically significant.

Results {#Sec7}
=======

Participant characteristics {#Sec8}
---------------------------

A total of 1296 participants aged 45.0 (35.0, 55.0) years old were enrolled, including 814 males and 482 females. The mean rGFR was 46.8 (29.8, 68.3) mL/min/1.73 m^2^, whereas the mean eGFR varied based on the different calculation formulae and ranged from 40.1 (19.2, 69.3) mL/min/1.73 m^2^ to 52.0 (21.6, 88.3) mL/min/1.73 m^2^. The basic characteristics of the participants are shown in Table [2](#Tab2){ref-type="table"}.Table 2Baseline characteristics of the participantsVariableValueAge, years45.0 (35.0, 55.0)Gender, male, n (%)814 (62.8%)Weight, kg62.0 (54.0, 70.0)Height, cm165.0 (158.0,170.0)Body surface area, m^2^1.7 ± 0.2Body mass index, Kg/m^2^22.9 (20.8, 25.4)Serum creatinine, mg/dL1.5 (1.0, 3.2)Serum cystatin C, mg/L1.7 (1.1, 2.9)rGFR, mL/min/1.73 m^2^46.8 (29.8, 68.3)eGFR, mL/min/1.73 m^2^ eGFR~scr~49.7 (19.6, 85.8) eGFR~cys~40.1 (19.2, 69.3) eGFR~scr~\_~cys~44.7 (18.6, 76.5) eGFR~a~\_~MDRD~48.9 (20.1, 81.0) eGFR~c~\_~MDRD~49.4 (19.1, 85.2) eGFR\_~MDRD~52.0 (21.6, 88.3)rGFR based on CKD stage, mL/min/1.73 m^2^ Stage 1 (*n* = 104)101.4 (96.2, 111.2) Stage 2 (*n* = 331)73.2 ± 8.6 Stage 3 (*n* = 529)43.5 (37.0, 51.5) Stage 4 (*n* = 220)23.6 (19.5, 27.0) Stage 5 (*n* = 112)10.8 (8.5, 13.2)*eGFR* estimated glomerular filtration rate, *rGFR* reference glomerular filtration rate, *CKD* chronic kidney disease, *MDRD* modification of diet in renal disease, *CKD-EPI* chronic kidney disease epidemiology collaboration

Performance of the six equations compared with the rGFR {#Sec9}
-------------------------------------------------------

The agreement or disagreement between the eGFR values and the rGFR values was analyzed by Bland-Altman plots (Fig. [1](#Fig1){ref-type="fig"}). According to these plots, the limits of the regression lines varied by each equation and were 73.5 for eGFR~scr~, 64.3 for eGFR~cys~, 64.7 for eGFR~scr_cys~, 90.3 for eGFR~a_MDRD~, 107.6 for eGFR~c_MDRD~, and 108.3 for eGFR\_~MDRD~. The eGFR~cys~ and eGFR~scr_cys~ equations performed similarly, showing the tightest limits of agreement among the six equations. The biases of eGFR~cys~ and eGFR~scr_cys~ (2.4 and −0.3, respectively) were much less than those of eGFR~scr~, eGFR~a_MDRD~, eGFR~c_MDRD~, and eGFR\_~MDRD~ (−4.8, −6.0, −8.9, and −11.5, respectively). Thus, the equations based on serum creatinine, eGFR~scr~, eGFR~a_MDRD~, eGFR~c_MDRD~, and eGFR\_~MDRD~, had poor agreement with the rGFR (eGFR~c_MDRD~ and eGFR\_~MDRD~ in particular). Using a combination of serum creatinine and cystatin C levels could improve the bias (−0.3 for eGFR~scr_cys~) of the equation.Fig. 1Bland-Altman plots of the rGFR and eGFR (mL/min/1.73 m^2^). eGFR~cys~ and eGFR~scr_cys~ performed similarly, showing the tightest limits of agreement among the six equations. eGFR~scr_cys~ showed the least bias among the six equations. eGFR~scr~ (**a**), eGFR~cys~ (**b**), eGFR~scr_cys~ (**c**), eGFR~a_MDRD~ (**d**), eGFR~c_MDRD~ (**e**), and eGFR\_~MDRD~ (**f**)

Diagnostic performance of the six equations for predicting renal insufficiency {#Sec10}
------------------------------------------------------------------------------

The diagnostic performance for predicting renal insufficiency based on the six equations is summarized in Table [3](#Tab3){ref-type="table"}. The AUC~60~ at a cutoff point of 59.6 mL/min/1.73 m^2^ in eGFR~scr_cys~ achieved the highest value (0.953), with a sensitivity of 87.6% and a specificity of 89.1%, suggesting the highest diagnostic accuracy for predicting renal insufficiency (*P* \< 0.05 vs. the others, except for eGFR\_~MDRD~). The optimal cutoff point of eGFR~cys~ for predicting renal insufficiency was 46.8 mL/min/1.73 m^2^, with a sensitivity of 93.6%, a specificity of 81.0%, and an AUC~60~ of 0.945. A revised cutoff value of eGFR~cys~ to 60.6 mL/min/1.73 m^2^ led to an improved specificity of 91.5% and a decreased sensitivity of 77.1%.Table 3Diagnostic performance of the six equations for predicting renal insufficiency (mL/min/1.73 m^2^)EquationeGFR~scr~eGFR~cys~eGFR~scr~\_~cys~eGFR~a~\_~MDRD~eGFR~c~\_~MDRD~eGFR\_~MDRD~Cutoff Value62.846.859.659.363.269.0AUC~60~0.948\*0.945\*0.9530.945\*0.948\*0.951^●^95% CI0.934--0.9590.931--0.9570.940--0.9640.933--0.9580.934--0.9590.938--0.962Youden index J0.7450.7450.7670.7430.7480.760 Sensitivity89.093.687.689.988.786.9 Specificity85.581.089.184.586.189.1Adjustment Cutoff Value60.460.660.260.060.359.8 Sensitivity90.377.186.788.189.992.2 Specificity84.191.589.184.783.981.7^●^ *P =* 0.4206 compared with eGFR~scr_cys~\**P* \< 0.05 compared with eGFR~scr_cys~

Misclassification of CKD stages by the six equations {#Sec11}
----------------------------------------------------

All equations had a high accuracy (range, 90.2--96.4%) for the diagnosis of stage 5 CKD; whereas all of them exhibited a moderate accuracy for the diagnosis of stage 3 CKD (Table [4](#Tab4){ref-type="table"}). In stage 1 CKD, eGFR~cys~ showed a higher percentage of misclassification than the other equations. Although eGFR~scr_cys~ exhibited the highest accuracy for estimating stage 2 CKD (49.8%), all equations seemed to perform poorly at predicting stage 2 and 4 CKD, as compared to the other CKD stages. In addition, based on the overall performance, eGFR~scr_cys~ had the highest kappa value (0.423), compared to the other five equations, suggesting that eGFR~scr_cys~ might be the best-performing equation in terms of accurate classification of the CKD stage.Table 4CKD stage classification based on eGFR estimation by the six equations (*n* = 1296)EquationCKD stage based on rGFRKappaStage 1Stage 2Stage 3Stage 4Stage 5eGFR~scr~98 (94.2%)121 (36.6%)263 (49.7%)83 (37.7%)107 (95.5%)0.392eGFR~cys~78 (75.0%)152 (45.9%)266 (50.3%)101 (45.9%)103 (92.0%)0.406eGFR~scr_cys~88 (84.6%)165 (49.8%)272 (51.4%)79 (35.9%)108 (96.4%)0.423eGFR~a_MDRD~93 (89.4%)137 (41.4%)269 (50.9%)87 (39.5%)107 (95.5%)0.407eGFR~c_MDRD~98 (94.2%)116 (35.0%)264 (49.9%)81 (36.8%)108 (96.4%)0.387eGFR~\_MDRD~99 (95.2%)109 (32.9%)264 (49.9%)95 (43.2%)101 (90.2%)0.388

Accuracy of the six eGFRs and the rGFR {#Sec12}
--------------------------------------

Among the six equations, eGFR~scr_cys~ had the smallest bias, whereas eGFR~cys~ exhibited the highest 30% accuracy and 50% accuracy (Table [5](#Tab5){ref-type="table"}).Table 5Comparison of bias and accuracy between the eGFR and rGFREquationBias (mL/min/1.73 m^2^)Bias of 95% CI30% accuracy50% accuracyeGFR~scr~\*−4.8−5.8, −3.851.2%77.6%eGFR~cys~\*2.41.5, 3.360.3%86.4%eGFR~scr~\_~cys~ ^▲^−0.3−1.2, 0.657.4%83.7%eGFR~a~\_~MDRD~\*−6.0−7.3, −4.852.1%76.4%eGFR~c~\_~MDRD~\*−8.9−10.4, −7.447.1%71.3%eGFR\_~MDRD~\*−11.5−13.0, −10.049.0%73.5%\*Compared with rGFR, *P* = 0.000▲Compared with rGFR, *P* = 0.550

Discussion {#Sec13}
==========

Each GFR-estimating equation has its own advantages for different stages of impaired renal function. In addition, their performances are affected by various factors. First, the serum creatinine level is determined by different methods. Compared with the Jaffe method, the enzymatic method is less affected by external factors \[[@CR14]--[@CR16]\]. A previous study has shown a significantly higher accuracy for the GFR-estimating equation using the enzymatic method to measure creatinine than that measured by the picric acid method when the rGFR is ≥60 mL/min/1.73 m^2^ \[[@CR17]\]. Second, the patients had different ages. The research performed by Roberts et al. showed that the MDRD equation overestimates the renal function in different age groups, which does not become apparent until after 65 years of age \[[@CR18]\]. Thus, the role of age in GFR estimation should be taken into consideration, and the elderly participants (over 65 years old) need to be observed separately. Therefore, this study only included patients aged 18--65 years old in order to minimize the possible bias of the study. Third, racial factors can affect the results. A meta-analysis has revealed that cystatin C has a better diagnostic value for CKD in the West than in Asia \[[@CR19]\], suggesting the performance of the equation differs in different racial and ethnic populations.

The inulin clearance rate has been considered as the gold standard, but it is an impractical method for estimating renal function, probably due to its costly, cumbersome features. Thus, radioisotopic methods, such as ^99^Tc^m^-DTPA, are commonly used in clinical applications \[[@CR20], [@CR21]\]. Serum creatinine and cystatin C represent two other indicators for predicting renal function. Cystatin C seems to perform better at predicting an early decrease in renal function \[[@CR22]--[@CR25]\], particularly in the elderly \[[@CR6]\], whereas serum creatinine is insensitive until the impairment is 50% or more \[[@CR26]\]. Our previous study revealed that the serum cystatin C measurement is more sensitive than that of serum creatinine for detecting an early decline in the rGFR \[[@CR22]\]. In the present study, the Bland-Altman plots showed that eGFR~cys~ and eGFR~scr_cys~ had similar low limits of agreement among the six equations, revealing higher agreement of cystatin C-based equations with the rGFR than the other four serum creatinine-based equations.

Accurate CKD stage classification facilitates the successful management of such patients. The performances of the GFR-estimating equations based on either serum creatinine or serum cystatin C vary with race/ethnicity \[[@CR7], [@CR19]\]. Thus, it is extremely important to identify the best-performing equation for CKD stage classification in specific populations. Previously, we found that the CKD-EPI equation based on the serum creatinine level exhibited a better performance than the MDRD equation in estimating the GFR in Chinese diabetics \[[@CR27]\]. In the present study, all six equations achieved high classification accuracy for stage 5 CKD (≥90.2%), no matter which serum creatinine or cystain C-based equation was used. However, their diagnostic efficiency differed greatly in CKD at stages 1--4. eGFR~cys~ had a low diagnostic accuracy in stage 1 CKD at a cutoff value of 46.8 mL/min/1.73 m^2^, which is lower than that used clinically, suggesting that cystatin C might underestimate mild renal dysfunction. Since serum creatinin- and cystatin C-based equations are most applicable in different CKD stages \[[@CR6]\], it has been reported that equations based on a combination of creatinine and cystatin C perform better than those equations based on creatinine or cystatin C alone \[[@CR9], [@CR28]\]. Among these equations, eGFR~scr_cys~ had the highest AUC~60~ among the six equations in the ROC~60~ analysis (*P* \< 0.05 vs. the others, except for eGFR\_~MDRD~), and it also achieved the top accuracy for overall CKD classification (kappa value, 0.423). These findings are consistent with those from Ying Zhu et al. \[[@CR29]\] and reveal that GFR-estimating equations based on the combination of serum creatinine and cystatin C levels may improve diagnostic efficiency for renal function.

Conclusions {#Sec14}
===========

This study has one particular strength. Considering that racial factors can affect the results, this study focused on data from a Chinese population for the purpose of identifying an appropriate GFR equation for the Chinese population. Also, this study only included Chinese patients aged 18--65 years old to minimize age-related bias of the study effectively.

This study also has some limitations. First, this was a retrospective, single-center study in China. Thus, caution must be used when generalizing the results of this study in a different population. Second, this study included adult patients aged from 18 to 65 years old. Considering the age-related decline in the GFR, we cannot be sure of the relevance of the results among children or elderly patients. Third, the role of some unmeasured factors (diet, muscle mass, etc.) that could have possibly influenced the observed association cannot be entirely ruled out. Forth, although ^99^Tc^m^-DTPA renal dynamic imaging has been widely as reference standard for clinical evaluation of renal function, it still has its disadvantages. Some researchers believe that ^99^Tc^m^-DTPA renal dynamic imaging may underestimate the true GFR \[[@CR30]\] because a very small part of ^99^Tc^m^-DTPA bounds to plasma proteins, although this is only speculated theoretically, not on the basis of pathological biopsy, and is usually neglected.

In conclusion, the CKD-EPI equations had higher agreement with the rGFR than the MDRD equations. Our study also found that the CKD-EPI~scr_cys~ equation achieved the top accuracy for overall CKD classification in the Chinese population. Compared with CKD-EPI~scr~ and CKD-EPI~cys~, the use of the combination of serum creatinine and cystatin C (CKD-EPI ~scr_cys~) levels could improve the bias of the equation and achieve a higher diagnostic accuracy for renal insufficiency. Each equation had its own advantages in predicting different CKD stages and needs further research.

^99^Tc^m^-DTPA

:   ^99^Tc^m^-diathylenetriamine pentaacetic acid

AUC

:   The areas under the ROC curve

CKD

:   Chronic kidney disease

CKD-EPI

:   Chronic Kidney Disease Epidemiology Collaboration

eGFR

:   Estimated GFR

GFR

:   Glomerular filtration rate

MDRD

:   Modification of Diet in Renal Disease

rGFR

:   Reference GFR

ROC

:   Receiver operating characteristic

We thank Professor An Shengli and Dr. Liu Wenjuan for their help with statistical analysis of the data.

Funding {#FPar1}
=======

This work was supported, in part, by grants from the National Natural Science Foundation of China (81570724) and the President Foundation of Nanfang Hospital Southern Medical University (2013C021).

Availability of data and materials {#FPar2}
==================================

The datasets analyzed during the current study are not publicly available due to the privacy of patients as well as joint ownership of research data in our institution. The data are available from the corresponding author on reasonable request, and the contact way can get through by email to hyxknfyy\@163.com or dial the phone number 13926066999.

GPL, QSW, and YMX conceived the study and participated in the design of the study; XHC analyzed the data and drafted the manuscript; YSQ andQZ analyzed the data; KH carried out the experiments. All authors read and approved the final manuscript.

Ethics approval and consent to participate {#FPar3}
==========================================

This study was conducted with the permission of the Ethics Committee of the Nanfang Hospital of Sothern Medical University. Written informed consent was obtained from each subject prior to participation.

Consent for publication {#FPar4}
=======================

Not applicable.

Competing interests {#FPar5}
===================

The authors declare that they have no competing interests.

Publisher's Note {#FPar6}
================

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
